These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 806708

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA, Jiménez León J, Martínez-Piñeiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS, Slocum HK, Rustum YM, Greco WR, Gaeta JF, Huben RP.
    J Urol; 1989 Dec; 142(6):1589-93. PubMed ID: 2511340
    [Abstract] [Full Text] [Related]

  • 26. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR, Griffin PP, Nocks BN, DeFuria MD, Daly JJ.
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [Abstract] [Full Text] [Related]

  • 27. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
    Puchner PJ, Veenema RJ, Tomashefsky P, Pinzus T, Tannenbaum T.
    Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
    [Abstract] [Full Text] [Related]

  • 28. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results].
    Durán R, Reina GR, Hontoria JM, Merino C, Olivier C, Carballido J.
    Actas Urol Esp; 1989 Jul; 13(1):19-23. PubMed ID: 2496583
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intractable bladder hemorrhage requiring cystectomy after use of intravesical thiotepa.
    Treible DP, Skinner D, Kasimain D, Friedman NB, Kern WH.
    Urology; 1987 Dec; 30(6):568-70. PubMed ID: 3120389
    [Abstract] [Full Text] [Related]

  • 31. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW, Prout GR, Smith W, Frable WJ, Minnis JE.
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract] [Full Text] [Related]

  • 32. [Spontaneously cured pancytopenia due to intravesical thio-tepa, apropos of one case].
    Archimbaud JP, Calcat P, Martel JP.
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):487-8. PubMed ID: 4216648
    [No Abstract] [Full Text] [Related]

  • 33. [Enhanced cell killing by thio-TEPA and urokinase (author's transl)].
    Taya T.
    Nihon Hinyokika Gakkai Zasshi; 1979 Jan; 70(1):15-27. PubMed ID: 107356
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
    Horn Y, Eidelman A, Walach N, Yuval E, Markowitz A.
    J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
    [Abstract] [Full Text] [Related]

  • 35. Severe pancytopenia associated with the use of intravesical thio-TEPA.
    Watkins WE, Kozak JA, Flanagan MJ.
    J Urol; 1967 Oct; 98(4):470-1. PubMed ID: 4964489
    [No Abstract] [Full Text] [Related]

  • 36. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT, Daly JJ, Irwin RJ, Prout GR.
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [Abstract] [Full Text] [Related]

  • 37. Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer.
    Melekos MD, Chionis HS, Paranychianakis GS, Dauaher HH.
    Cancer; 1993 Sep 01; 72(5):1749-55. PubMed ID: 8348504
    [Abstract] [Full Text] [Related]

  • 38. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH, Ye G, Wang XW, Jin HS, Zhang YN, Yan ZL.
    Ai Zheng; 2008 Nov 01; 27(11):1208-11. PubMed ID: 19000455
    [Abstract] [Full Text] [Related]

  • 39. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
    Wu WJ, Ke HL, Yang YH, Li CC, Chou YH, Huang CH.
    J Urol; 2010 Jan 01; 183(1):56-61. PubMed ID: 19913833
    [Abstract] [Full Text] [Related]

  • 40. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
    Kobayashi M, Sugaya Y, Yuzawa M, Morita T, Kobayashi Y, Tokue A.
    Hinyokika Kiyo; 1998 Dec 01; 44(12):861-4. PubMed ID: 10028430
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.